Results 351 to 360 of about 5,260,709 (398)

Evolution of tumor stress response during cytoreductive surgery for ovarian cancer. [PDF]

iScience
Praiss AM, Moukarzel LA, Zhu Y, Longhini ALF, Derakhshan F, Hoang T, Pesci G, Green H, Ozsoy MA, Hanlon E, Kahn R, Brodeur MN, Sia T, Abu-Rustum NR, Gardner G, Roche KL, Sonoda Y, Zivanovic O, Chi DS, Merghoub T, Gardner R, Weigelt B, Zamarin D.   +22 more
europepmc   +1 more source

Krüppel‐like factor 4 transcription factor in blood–brain barrier endothelial cells: A potential role in Alzheimer's disease

Animal Models and Experimental Medicine, EarlyView.
KLF4 (Krüppel‐like factor 4) plays a protective role in blood–brain barrier (BBB). KLF4 plays an ambiguous role in the central nervous system. KLF4 in the BBB endothelial cells could be a potential target for Alzheimer's disease. Abstract Alzheimer's disease is the most prevalent chronic neurodegenerative disorder worldwide, with no sufficient cure ...
Ziying Wei, Chunhua Liu, Jianyu Chen, Yuxiao Yao, Dajiang Qin   +4 more
wiley   +1 more source

Sex hormones and immune regulation in ovarian cancer. [PDF]

Discov Oncol
Zhao R, Lian W, Xu Q.
europepmc   +1 more source

Label‐Free Microscale Technologies for Isolation of Heterogeneous Circulating Tumor Cells

Advanced NanoBiomed Research, EarlyView.
The isolation of circulating tumor cells (CTCs) from liquid biopsy samples is crucial for cancer treatment and monitoring. This review evaluates primary label‐free isolation methods for capturing heterogeneous CTCs and examines their potential to provide deeper insights into tumor heterogeneity and dynamics of cancer progression.
Gürhan Özkayar, Esma Derin, Georg R. Pesch, John W. M. Martens, Peter ten Dijke, Pouyan E. Boukany   +5 more
wiley   +1 more source

Recent Advances in Cancer Cell Membrane‐Based Nanoparticles and Cancer Cell‐Derived Small Extracellular Vesicles as Drug Delivery Platforms

Advanced NanoBiomed Research, EarlyView.
Cancer cell membrane‐based nanoparticles (CCM‐NPs) and cancer cell‐derived small extracellular vesicles (CsEVs) are emerging as promising drug delivery systems for targeted cancer treatment. Advances in nanotechnology have paved the way for innovative drug delivery systems that enhance the effectiveness of cancer treatment.
Wei Zhang, Jingjing Wang, Long Ngo, Li Li, Yuling Wang   +4 more
wiley   +1 more source

Evaluating Ovarian Cancer Risk-Reducing Salpingectomy Acceptance: A Survey. [PDF]

Cancer Res Commun
Lukey A, Sowamber R, Huntsman D, Pearce CL, Howard AF, Meza R, Law MR, Phung MT, Hanley GE.   +8 more
europepmc   +1 more source

Concise Total Syntheses of Leuconoxine‐Type Alkaloids Enabled by Palladium/Norbornene‐Catalyzed Pyrrole Difunctionalization

Angewandte Chemie, EarlyView.
Concise total syntheses of five leuconoxine alkaloids have been achieved using a pyrrole‐centered strategy, which features a newly developed palladium/norbornene‐catalyzed pyrrole double C─H functionalization method, a divergent late‐stage oxidative dearomatization tactic, and no use of protecting groups.
Xin Liu, Yun Zhou, Yu Meng, Qi Zhu, Renhe Li, Guangbin Dong   +5 more
wiley   +1 more source

The role of MUC16 in tumor biology and tumor immunology in ovarian cancer. [PDF]

BMC Cancer
Yang N, Zhou X, Gong Y, Deng Z.
europepmc   +1 more source

Switching on Supramolecular DNA Junction Binding Using a Human Enzyme

Angewandte Chemie, EarlyView.
Stimulus responsive control of DNA junction formation: Enzyme action cleaves flexible arms from a metallo‐supramolecular cylinder, transforming an inert metallo‐supramolecular structure into an active metallo‐supramolecular agent, and switching on its ability to assemble, bind and stabilize DNA three‐way junction structures.
Subhendu Karmakar, Samuel J. Dettmer, Catherine A. J. Hooper, Nikolas J. Hodges, Michael J. Hannon   +4 more
wiley   +1 more source

Assessment of lncRNA biomarkers based on NETs for prognosis and therapeutic response in ovarian cancer. [PDF]

Sci Rep
Wang J, Liang Y, Meng Y, Chen J, Fang L, Yang H, Li P.   +6 more
europepmc   +1 more source